PET-CT in Lymphoma Among the Eldery
NCT07259941 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 63
Last updated 2025-12-02
Summary
This study investigates PET-CT imaging patterns and metabolic parameters in elderly patients (≥60 years) diagnosed with lymphoma, aiming to enhance diagnostic accuracy and prognosis using 18F-FDG PET/CT scans.
Conditions
- PET-CT
- Lymphoma
- Elderly
- Metabolic Parameters
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2027-01-01
- Completion
- 2027-02-01
More Related Trials
-
Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma
NCT06737835 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
NCT04317313 ·Status: COMPLETED
-
The Performance of Multi-tracer Multimodality PET in Lymphoma
NCT05004961 ·Status: UNKNOWN
-
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
NCT02733887 ·Status: UNKNOWN ·Phase: NA
-
The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
NCT00498667 ·Status: WITHDRAWN
-
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
NCT02490891 ·Status: COMPLETED ·Phase: PHASE2
-
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma
NCT05411250 ·Status: UNKNOWN
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL
NCT05113576 ·Status: COMPLETED
-
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
NCT05390632 ·Status: UNKNOWN
-
Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
NCT01436591 ·Status: TERMINATED
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
Dual Time Point PET Imaging in Lymphoma
NCT00297557 ·Status: UNKNOWN
-
Wholebody MRI In Lung Cancer StagiNg
NCT02716051 ·Status: COMPLETED ·Phase: NA
-
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
NCT01410630 ·Status: COMPLETED
-
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
NCT03051555 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051581 ·Status: UNKNOWN ·Phase: NA
-
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma
NCT03973164 ·Status: COMPLETED
-
Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma
NCT04931875 ·Status: UNKNOWN
-
FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma
NCT00530179 ·Status: COMPLETED ·Phase: NA
-
Molecular and Whole-body MR Imaging in Lymphomas
NCT02389101 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
NCT03121456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING